CWA Asset Management Group’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$283K Buy
1,495
+94
+7% +$17.7K 0.01% 608
2026
Q1
$276K Sell
1,401
-154
-10% -$29.7K 0.01% 577
2025
Q4
$286K Sell
1,555
-20
-1% -$3.51K 0.01% 555
2025
Q3
$242K Sell
1,575
-72
-4% -$10.9K 0.01% 603
2025
Q2
$230K Buy
1,647
+143
+10% +$20K 0.01% 589
2025
Q1
$221K Buy
+1,504
New +$218K 0.01% 570
2024
Q4
Sell
-1,706
Closed -$266K 564
2024
Q3
$266K Buy
+1,706
New +$275K 0.01% 503
2023
Q2
Sell
-1,703
Closed -$236K 358
2023
Q1
$236K Hold
1,703
0.02% 286
2022
Q4
$231K Buy
+1,703
New +$214K 0.02% 292
2022
Q3
Sell
-1,692
Closed -$224K 304
2022
Q2
$224K Hold
1,692
0.02% 269
2022
Q1
$224K Sell
1,692
-275
-14% -$33K 0.02% 271
2021
Q4
$229K Buy
1,967
+149
+8% +$17.5K 0.02% 268
2021
Q3
$218K Buy
1,818
+26
+1% +$3.03K 0.02% 256
2021
Q2
$216K Buy
+1,792
New +$197K 0.02% 259
2020
Q4
Sell
-2,892
Closed -$317K 267
2020
Q3
$317K Buy
2,892
+200
+7% +$22.2K 0.04% 168
2020
Q2
$285K Buy
2,692
+192
+8% +$19.8K 0.05% 166
2020
Q1
$223K Sell
2,500
-2,500
-50% -$235K 0.04% 196
2019
Q4
$499K Hold
5,000
0.08% 139
2019
Q3
$446K Hold
5,000
0.07% 137
2019
Q2
$413K Buy
+5,000
New +$392K 0.07% 145

Other funds holding AZN

CWA Asset Management Group's AZN Position: Q2 2026 in Review

CWA Asset Management Group increased its AstraZeneca (AZN) stake by 6.7% in Q2 2026, buying an estimated $17.7K and bringing the position to 1,495 shares worth $283K. The position accounts for 0.01% of the portfolio, ranked #608.

CWA Asset Management Group first reported a position in AZN in Q2 2019 and has held it in 20 quarters since. The position peaked at $499K in Q4 2019. 534 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • CWA Asset Management Group held 1,495 shares of AstraZeneca worth $283K as of Q2 2026.
  • CWA Asset Management Group bought 94 AstraZeneca shares in Q2 2026, an estimated $17.7K.
  • AstraZeneca made up 0.01% of CWA Asset Management Group's portfolio in Q2 2026, its #608 holding.
  • CWA Asset Management Group first reported a position in AstraZeneca in Q2 2019 and has held it in 20 quarters since.
  • CWA Asset Management Group's AstraZeneca position peaked at $499K in Q4 2019.
  • 534 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.